Total: £ 56.28
Published Date: 2026-04-29 | Pages: 136 | Tables: 133 | Medical Devices & Consumables
The global Nuclear Medical Device market was valued at US$ 3401 million in 2025 and is anticipated to reach US$ 5273 million by 2032, at a CAGR of 6.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Nuclear Medical Device competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Nuclear Medical Device refers to advanced medical equipment that utilizes radionuclides, nuclear detection technologies, and related imaging and therapeutic systems for disease diagnosis, molecular imaging analysis, precision radiotherapy, and radionuclide therapy. Key products include Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), radiopharmaceutical injectors, gamma cameras, cyclotrons, and specialized therapeutic devices for nuclear medicine. These devices integrate cutting-edge achievements in medical imaging, molecular biology, and nuclear physics, playing an irreplaceable role in the early detection and personalized treatment of major diseases such as cancer, cardiovascular disorders, and neurological conditions. Nuclear medical devices not only reflect the growing demand for precision medicine and high-end imaging in healthcare systems but also represent a crucial direction for the deep integration of intelligent healthcare and life sciences.In 2024, global Nuclear Medical Device production reached approximately 1690 units, with an average global market price of around K US$ 1825.6 perunit.
With the acceleration of global population aging and the high prevalence of cancer, cardiovascular, and neurological diseases, the clinical applications of nuclear medical devices are expanding. Governments worldwide are increasing policy support and funding for advanced medical equipment, while healthcare providers are demanding higher accuracy in diagnostics and personalized therapy. At the same time, pharmaceutical companies and research institutes are advancing molecular imaging and radiopharmaceutical development, further enhancing the value of these devices and driving robust market growth.
The nuclear medical device industry requires substantial R&D investment and sophisticated manufacturing processes. High device costs, combined with complex installation and maintenance, remain key barriers for widespread adoption. The supply of radionuclides is dependent on upstream nuclear facilities and international policies, creating uncertainty. Additionally, strict regulations on radiation safety, quality certifications, and cross-border approvals increase compliance costs. Market competition is intensifying, with international leaders maintaining significant technological and distribution advantages over local players.
Future clinical demand will increasingly focus on early diagnosis and precision therapy. Nuclear medical devices will play a growing role in oncological molecular imaging, personalized radiotherapy, and systemic metabolic monitoring. Large tertiary hospitals will continue to dominate procurement, while regional medical centers and specialized hospitals are gradually increasing adoption. With the integration of AI and big data, nuclear medical devices are evolving from imaging acquisition tools into multimodal medical information platforms that meet clinical needs for real-time, intelligent, and visualized healthcare.
The core raw materials for nuclear medical devices include high-purity scintillation crystals for detectors, rare isotopes for accelerators and emission sources, and high-stability precision electronics and specialty metals. Scintillation crystals such as sodium iodide and cesium iodide directly affect imaging quality, but their production is complex and costly. Radionuclide supply depends heavily on a limited number of nuclear reactors and cyclotrons, making it closely tied to international cooperation. Meanwhile, the growing demand for advanced electronic components and radiation-resistant materials is fostering cross-industry collaboration with semiconductors and materials science.
This report delivers a comprehensive overview of the global Nuclear Medical Device market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Nuclear Medical Device. The Nuclear Medical Device market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Nuclear Medical Device market comprehensively. Regional market sizes by Type, by Application, by Clinical Indication, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Nuclear Medical Device manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Siemens Healthineers (Varian)
Elekta
Accuray
Shanghai United Imaging
LinaTech
Neusoft
SHINVA Medical
China Isotope & Radiation
Huiheng Group
ET Medical
YingKang Life (MASEP)
OUR United Gorp
Best Theratronics
Ion Beam Applications
BEBIG Medical
Mevion Medical Systems
Best Cyclotron Systems
Advanced Cyclotron Systems
Sumitomo Heavy Industries
Segment by Type
External Beam Radiotherapy (EBRT) Equipment
Brachytherapy Equipment
Segment by Clinical Indication
Oncology
Cardiology
Neurology
Other
Segment by Radionuclide Type
Beta Emitters
Alpha Emitters
Gamma Emitters
by Application
Hospitals
Radiation Therapy Center
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Clinical Indication, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Nuclear Medical Device manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Nuclear Medical Device sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Nuclear Medical Device Market Overview
1.1 Product Definition
1.2 Nuclear Medical Device by Type
1.2.1 Global Nuclear Medical Device Market Value by Type: 2025 vs 2032
1.2.2 External Beam Radiotherapy (EBRT) Equipment
1.2.3 Brachytherapy Equipment
1.3 Nuclear Medical Device by Clinical Indication
1.3.1 Global Nuclear Medical Device Market Value by Clinical Indication: 2025 vs 2032
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Neurology
1.3.5 Other
1.4 Nuclear Medical Device by Radionuclide Type
1.4.1 Global Nuclear Medical Device Market Value by Radionuclide Type: 2025 vs 2032
1.4.2 Beta Emitters
1.4.3 Alpha Emitters
1.4.4 Gamma Emitters
1.5 Nuclear Medical Device by Application
1.5.1 Global Nuclear Medical Device Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Radiation Therapy Center
1.6 Global Nuclear Medical Device Market Size Estimates and Forecasts
1.6.1 Global Nuclear Medical Device Revenue 2021–2032
1.6.2 Global Nuclear Medical Device Sales 2021–2032
1.6.3 Global Nuclear Medical Device Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Nuclear Medical Device Market Competition by Manufacturers
2.1 Global Nuclear Medical Device Sales Market Share by Manufacturers (2021–2026)
2.2 Global Nuclear Medical Device Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Nuclear Medical Device Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Nuclear Medical Device, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Nuclear Medical Device, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Nuclear Medical Device, Product Types and Applications
2.7 Global Key Manufacturers of Nuclear Medical Device, Date of Entry into the Industry
2.8 Global Nuclear Medical Device Market Competitive Situation and Trends
2.8.1 Global Nuclear Medical Device Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Nuclear Medical Device Players Market Share by Revenue
2.8.3 Global Nuclear Medical Device Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Nuclear Medical Device Market Scenario by Region
3.1 Global Nuclear Medical Device Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Nuclear Medical Device Sales by Region: 2021–2032
3.2.1 Global Nuclear Medical Device Sales by Region: 2021–2026
3.2.2 Global Nuclear Medical Device Sales by Region: 2027–2032
3.3 Global Nuclear Medical Device Revenue by Region: 2021–2032
3.3.1 Global Nuclear Medical Device Revenue by Region: 2021–2026
3.3.2 Global Nuclear Medical Device Revenue by Region: 2027–2032
3.4 North America Nuclear Medical Device Market Facts & Figures by Country
3.4.1 North America Nuclear Medical Device Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Nuclear Medical Device Sales by Country (2021–2032)
3.4.3 North America Nuclear Medical Device Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Medical Device Market Facts & Figures by Country
3.5.1 Europe Nuclear Medical Device Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Nuclear Medical Device Sales by Country (2021–2032)
3.5.3 Europe Nuclear Medical Device Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Medical Device Market Facts & Figures by Region
3.6.1 Asia Pacific Nuclear Medical Device Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Nuclear Medical Device Sales by Region (2021–2032)
3.6.3 Asia Pacific Nuclear Medical Device Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nuclear Medical Device Market Facts & Figures by Country
3.7.1 Latin America Nuclear Medical Device Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Nuclear Medical Device Sales by Country (2021–2032)
3.7.3 Latin America Nuclear Medical Device Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Medical Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Medical Device Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Nuclear Medical Device Sales by Country (2021–2032)
3.8.3 Middle East and Africa Nuclear Medical Device Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Medical Device Sales by Type (2021–2032)
4.1.1 Global Nuclear Medical Device Sales by Type (2021–2026)
4.1.2 Global Nuclear Medical Device Sales by Type (2027–2032)
4.1.3 Global Nuclear Medical Device Sales Market Share by Type (2021–2032)
4.2 Global Nuclear Medical Device Revenue by Type (2021–2032)
4.2.1 Global Nuclear Medical Device Revenue by Type (2021–2026)
4.2.2 Global Nuclear Medical Device Revenue by Type (2027–2032)
4.2.3 Global Nuclear Medical Device Revenue Market Share by Type (2021–2032)
4.3 Global Nuclear Medical Device Price by Type (2021–2032)
5 Segment by Application
5.1 Global Nuclear Medical Device Sales by Application (2021–2032)
5.1.1 Global Nuclear Medical Device Sales by Application (2021–2026)
5.1.2 Global Nuclear Medical Device Sales by Application (2027–2032)
5.1.3 Global Nuclear Medical Device Sales Market Share by Application (2021–2032)
5.2 Global Nuclear Medical Device Revenue by Application (2021–2032)
5.2.1 Global Nuclear Medical Device Revenue by Application (2021–2026)
5.2.2 Global Nuclear Medical Device Revenue by Application (2027–2032)
5.2.3 Global Nuclear Medical Device Revenue Market Share by Application (2021–2032)
5.3 Global Nuclear Medical Device Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Siemens Healthineers (Varian)
6.1.1 Siemens Healthineers (Varian) Company Information
6.1.2 Siemens Healthineers (Varian) Description and Business Overview
6.1.3 Siemens Healthineers (Varian) Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Siemens Healthineers (Varian) Nuclear Medical Device Product Portfolio
6.1.5 Siemens Healthineers (Varian) Recent Developments/Updates
6.2 Elekta
6.2.1 Elekta Company Information
6.2.2 Elekta Description and Business Overview
6.2.3 Elekta Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Elekta Nuclear Medical Device Product Portfolio
6.2.5 Elekta Recent Developments/Updates
6.3 Accuray
6.3.1 Accuray Company Information
6.3.2 Accuray Description and Business Overview
6.3.3 Accuray Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Accuray Nuclear Medical Device Product Portfolio
6.3.5 Accuray Recent Developments/Updates
6.4 Shanghai United Imaging
6.4.1 Shanghai United Imaging Company Information
6.4.2 Shanghai United Imaging Description and Business Overview
6.4.3 Shanghai United Imaging Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Shanghai United Imaging Nuclear Medical Device Product Portfolio
6.4.5 Shanghai United Imaging Recent Developments/Updates
6.5 LinaTech
6.5.1 LinaTech Company Information
6.5.2 LinaTech Description and Business Overview
6.5.3 LinaTech Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 LinaTech Nuclear Medical Device Product Portfolio
6.5.5 LinaTech Recent Developments/Updates
6.6 Neusoft
6.6.1 Neusoft Company Information
6.6.2 Neusoft Description and Business Overview
6.6.3 Neusoft Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Neusoft Nuclear Medical Device Product Portfolio
6.6.5 Neusoft Recent Developments/Updates
6.7 SHINVA Medical
6.7.1 SHINVA Medical Company Information
6.7.2 SHINVA Medical Description and Business Overview
6.7.3 SHINVA Medical Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 SHINVA Medical Nuclear Medical Device Product Portfolio
6.7.5 SHINVA Medical Recent Developments/Updates
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Company Information
6.8.2 China Isotope & Radiation Description and Business Overview
6.8.3 China Isotope & Radiation Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 China Isotope & Radiation Nuclear Medical Device Product Portfolio
6.8.5 China Isotope & Radiation Recent Developments/Updates
6.9 Huiheng Group
6.9.1 Huiheng Group Company Information
6.9.2 Huiheng Group Description and Business Overview
6.9.3 Huiheng Group Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Huiheng Group Nuclear Medical Device Product Portfolio
6.9.5 Huiheng Group Recent Developments/Updates
6.10 ET Medical
6.10.1 ET Medical Company Information
6.10.2 ET Medical Description and Business Overview
6.10.3 ET Medical Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 ET Medical Nuclear Medical Device Product Portfolio
6.10.5 ET Medical Recent Developments/Updates
6.11 YingKang Life (MASEP)
6.11.1 YingKang Life (MASEP) Company Information
6.11.2 YingKang Life (MASEP) Description and Business Overview
6.11.3 YingKang Life (MASEP) Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 YingKang Life (MASEP) Nuclear Medical Device Product Portfolio
6.11.5 YingKang Life (MASEP) Recent Developments/Updates
6.12 OUR United Gorp
6.12.1 OUR United Gorp Company Information
6.12.2 OUR United Gorp Description and Business Overview
6.12.3 OUR United Gorp Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 OUR United Gorp Nuclear Medical Device Product Portfolio
6.12.5 OUR United Gorp Recent Developments/Updates
6.13 Best Theratronics
6.13.1 Best Theratronics Company Information
6.13.2 Best Theratronics Description and Business Overview
6.13.3 Best Theratronics Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Best Theratronics Nuclear Medical Device Product Portfolio
6.13.5 Best Theratronics Recent Developments/Updates
6.14 Ion Beam Applications
6.14.1 Ion Beam Applications Company Information
6.14.2 Ion Beam Applications Description and Business Overview
6.14.3 Ion Beam Applications Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Ion Beam Applications Nuclear Medical Device Product Portfolio
6.14.5 Ion Beam Applications Recent Developments/Updates
6.15 BEBIG Medical
6.15.1 BEBIG Medical Company Information
6.15.2 BEBIG Medical Description and Business Overview
6.15.3 BEBIG Medical Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 BEBIG Medical Nuclear Medical Device Product Portfolio
6.15.5 BEBIG Medical Recent Developments/Updates
6.16 Mevion Medical Systems
6.16.1 Mevion Medical Systems Company Information
6.16.2 Mevion Medical Systems Description and Business Overview
6.16.3 Mevion Medical Systems Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Mevion Medical Systems Nuclear Medical Device Product Portfolio
6.16.5 Mevion Medical Systems Recent Developments/Updates
6.17 Best Cyclotron Systems
6.17.1 Best Cyclotron Systems Company Information
6.17.2 Best Cyclotron Systems Description and Business Overview
6.17.3 Best Cyclotron Systems Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Best Cyclotron Systems Nuclear Medical Device Product Portfolio
6.17.5 Best Cyclotron Systems Recent Developments/Updates
6.18 Advanced Cyclotron Systems
6.18.1 Advanced Cyclotron Systems Company Information
6.18.2 Advanced Cyclotron Systems Description and Business Overview
6.18.3 Advanced Cyclotron Systems Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Advanced Cyclotron Systems Nuclear Medical Device Product Portfolio
6.18.5 Advanced Cyclotron Systems Recent Developments/Updates
6.19 Sumitomo Heavy Industries
6.19.1 Sumitomo Heavy Industries Company Information
6.19.2 Sumitomo Heavy Industries Description and Business Overview
6.19.3 Sumitomo Heavy Industries Nuclear Medical Device Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Sumitomo Heavy Industries Nuclear Medical Device Product Portfolio
6.19.5 Sumitomo Heavy Industries Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Medical Device Industry Chain Analysis
7.2 Nuclear Medical Device Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Medical Device Production Mode & Process Analysis
7.4 Nuclear Medical Device Sales and Marketing
7.4.1 Nuclear Medical Device Sales Channels
7.4.2 Nuclear Medical Device Distributors
7.5 Nuclear Medical Device Customer Analysis
8 Nuclear Medical Device Market Dynamics
8.1 Nuclear Medical Device Industry Trends
8.2 Nuclear Medical Device Market Drivers
8.3 Nuclear Medical Device Market Challenges
8.4 Nuclear Medical Device Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nuclear Medical Device Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Nuclear Medical Device Market Value by Clinical Indication (US$ Million), 2025 vs 2032
Table 3. Global Nuclear Medical Device Market Value by Radionuclide Type (US$ Million), 2025 vs 2032
Table 4. Global Nuclear Medical Device Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Nuclear Medical Device Market Competitive Situation by Manufacturers in 2025
Table 6. Global Nuclear Medical Device Sales (Units) of Key Manufacturers (2021–2026)
Table 7. Global Nuclear Medical Device Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Nuclear Medical Device Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Nuclear Medical Device Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Nuclear Medical Device Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Nuclear Medical Device, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Nuclear Medical Device, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Nuclear Medical Device, Product Types and Applications
Table 14. Global Key Manufacturers of Nuclear Medical Device, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Nuclear Medical Device Companies by Tier (Tier 1, Tier 2, Tier 3), based on Nuclear Medical Device Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Nuclear Medical Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Nuclear Medical Device Sales by Region (Units), 2021–2026
Table 20. Global Nuclear Medical Device Sales Market Share by Region (2021–2026)
Table 21. Global Nuclear Medical Device Sales by Region (Units), 2027–2032
Table 22. Global Nuclear Medical Device Sales Market Share by Region (2027–2032)
Table 23. Global Nuclear Medical Device Revenue by Region (US$ Million), 2021–2026
Table 24. Global Nuclear Medical Device Revenue Market Share by Region (2021–2026)
Table 25. Global Nuclear Medical Device Revenue by Region (US$ Million), 2027–2032
Table 26. Global Nuclear Medical Device Revenue Market Share by Region (2027–2032)
Table 27. North America Nuclear Medical Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Nuclear Medical Device Sales by Country (Units), 2021–2026
Table 29. North America Nuclear Medical Device Sales by Country (Units), 2027–2032
Table 30. North America Nuclear Medical Device Revenue by Country (US$ Million), 2021–2026
Table 31. North America Nuclear Medical Device Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Nuclear Medical Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Nuclear Medical Device Sales by Country (Units), 2021–2026
Table 34. Europe Nuclear Medical Device Sales by Country (Units), 2027–2032
Table 35. Europe Nuclear Medical Device Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Nuclear Medical Device Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Nuclear Medical Device Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Nuclear Medical Device Sales by Region (Units), 2021–2026
Table 39. Asia Pacific Nuclear Medical Device Sales by Region (Units), 2027–2032
Table 40. Asia Pacific Nuclear Medical Device Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Nuclear Medical Device Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Nuclear Medical Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Nuclear Medical Device Sales by Country (Units), 2021–2026
Table 44. Latin America Nuclear Medical Device Sales by Country (Units), 2027–2032
Table 45. Latin America Nuclear Medical Device Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Nuclear Medical Device Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Nuclear Medical Device Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Nuclear Medical Device Sales by Country (Units), 2021–2026
Table 49. Middle East and Africa Nuclear Medical Device Sales by Country (Units), 2027–2032
Table 50. Middle East and Africa Nuclear Medical Device Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Nuclear Medical Device Revenue by Country (US$ Million), 2027–2032
Table 52. Global Nuclear Medical Device Sales (Units) by Type (2021–2026)
Table 53. Global Nuclear Medical Device Sales (Units) by Type (2027–2032)
Table 54. Global Nuclear Medical Device Sales Market Share by Type (2021–2026)
Table 55. Global Nuclear Medical Device Sales Market Share by Type (2027–2032)
Table 56. Global Nuclear Medical Device Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Nuclear Medical Device Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Nuclear Medical Device Revenue Market Share by Type (2021–2026)
Table 59. Global Nuclear Medical Device Revenue Market Share by Type (2027–2032)
Table 60. Global Nuclear Medical Device Price (K US$/Unit) by Type (2021–2026)
Table 61. Global Nuclear Medical Device Price (K US$/Unit) by Type (2027–2032)
Table 62. Global Nuclear Medical Device Sales (Units) by Application (2021–2026)
Table 63. Global Nuclear Medical Device Sales (Units) by Application (2027–2032)
Table 64. Global Nuclear Medical Device Sales Market Share by Application (2021–2026)
Table 65. Global Nuclear Medical Device Sales Market Share by Application (2027–2032)
Table 66. Global Nuclear Medical Device Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Nuclear Medical Device Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Nuclear Medical Device Revenue Market Share by Application (2021–2026)
Table 69. Global Nuclear Medical Device Revenue Market Share by Application (2027–2032)
Table 70. Global Nuclear Medical Device Price (K US$/Unit) by Application (2021–2026)
Table 71. Global Nuclear Medical Device Price (K US$/Unit) by Application (2027–2032)
Table 72. Siemens Healthineers (Varian) Company Information
Table 73. Siemens Healthineers (Varian) Description and Business Overview
Table 74. Siemens Healthineers (Varian) Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 75. Siemens Healthineers (Varian) Nuclear Medical Device Product
Table 76. Siemens Healthineers (Varian) Recent Developments/Updates
Table 77. Elekta Company Information
Table 78. Elekta Description and Business Overview
Table 79. Elekta Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 80. Elekta Nuclear Medical Device Product
Table 81. Elekta Recent Developments/Updates
Table 82. Accuray Company Information
Table 83. Accuray Description and Business Overview
Table 84. Accuray Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 85. Accuray Nuclear Medical Device Product
Table 86. Accuray Recent Developments/Updates
Table 87. Shanghai United Imaging Company Information
Table 88. Shanghai United Imaging Description and Business Overview
Table 89. Shanghai United Imaging Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 90. Shanghai United Imaging Nuclear Medical Device Product
Table 91. Shanghai United Imaging Recent Developments/Updates
Table 92. LinaTech Company Information
Table 93. LinaTech Description and Business Overview
Table 94. LinaTech Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 95. LinaTech Nuclear Medical Device Product
Table 96. LinaTech Recent Developments/Updates
Table 97. Neusoft Company Information
Table 98. Neusoft Description and Business Overview
Table 99. Neusoft Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 100. Neusoft Nuclear Medical Device Product
Table 101. Neusoft Recent Developments/Updates
Table 102. SHINVA Medical Company Information
Table 103. SHINVA Medical Description and Business Overview
Table 104. SHINVA Medical Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 105. SHINVA Medical Nuclear Medical Device Product
Table 106. SHINVA Medical Recent Developments/Updates
Table 107. China Isotope & Radiation Company Information
Table 108. China Isotope & Radiation Description and Business Overview
Table 109. China Isotope & Radiation Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 110. China Isotope & Radiation Nuclear Medical Device Product
Table 111. China Isotope & Radiation Recent Developments/Updates
Table 112. Huiheng Group Company Information
Table 113. Huiheng Group Description and Business Overview
Table 114. Huiheng Group Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 115. Huiheng Group Nuclear Medical Device Product
Table 116. Huiheng Group Recent Developments/Updates
Table 117. ET Medical Company Information
Table 118. ET Medical Description and Business Overview
Table 119. ET Medical Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 120. ET Medical Nuclear Medical Device Product
Table 121. ET Medical Recent Developments/Updates
Table 122. YingKang Life (MASEP) Company Information
Table 123. YingKang Life (MASEP) Description and Business Overview
Table 124. YingKang Life (MASEP) Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 125. YingKang Life (MASEP) Nuclear Medical Device Product
Table 126. YingKang Life (MASEP) Recent Developments/Updates
Table 127. OUR United Gorp Company Information
Table 128. OUR United Gorp Description and Business Overview
Table 129. OUR United Gorp Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 130. OUR United Gorp Nuclear Medical Device Product
Table 131. OUR United Gorp Recent Developments/Updates
Table 132. Best Theratronics Company Information
Table 133. Best Theratronics Description and Business Overview
Table 134. Best Theratronics Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 135. Best Theratronics Nuclear Medical Device Product
Table 136. Best Theratronics Recent Developments/Updates
Table 137. Ion Beam Applications Company Information
Table 138. Ion Beam Applications Description and Business Overview
Table 139. Ion Beam Applications Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 140. Ion Beam Applications Nuclear Medical Device Product
Table 141. Ion Beam Applications Recent Developments/Updates
Table 142. BEBIG Medical Company Information
Table 143. BEBIG Medical Description and Business Overview
Table 144. BEBIG Medical Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 145. BEBIG Medical Nuclear Medical Device Product
Table 146. BEBIG Medical Recent Developments/Updates
Table 147. Mevion Medical Systems Company Information
Table 148. Mevion Medical Systems Description and Business Overview
Table 149. Mevion Medical Systems Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 150. Mevion Medical Systems Nuclear Medical Device Product
Table 151. Mevion Medical Systems Recent Developments/Updates
Table 152. Best Cyclotron Systems Company Information
Table 153. Best Cyclotron Systems Description and Business Overview
Table 154. Best Cyclotron Systems Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 155. Best Cyclotron Systems Nuclear Medical Device Product
Table 156. Best Cyclotron Systems Recent Developments/Updates
Table 157. Advanced Cyclotron Systems Company Information
Table 158. Advanced Cyclotron Systems Description and Business Overview
Table 159. Advanced Cyclotron Systems Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 160. Advanced Cyclotron Systems Nuclear Medical Device Product
Table 161. Advanced Cyclotron Systems Recent Developments/Updates
Table 162. Sumitomo Heavy Industries Company Information
Table 163. Sumitomo Heavy Industries Description and Business Overview
Table 164. Sumitomo Heavy Industries Nuclear Medical Device Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
Table 165. Sumitomo Heavy Industries Nuclear Medical Device Product
Table 166. Sumitomo Heavy Industries Recent Developments/Updates
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Nuclear Medical Device Distributors List
Table 170. Nuclear Medical Device Customers List
Table 171. Nuclear Medical Device Market Trends
Table 172. Nuclear Medical Device Market Drivers
Table 173. Nuclear Medical Device Market Challenges
Table 174. Nuclear Medical Device Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
Table 178. Authors List of This Report
List of Figures
Figure 1. Product Picture of Nuclear Medical Device
Figure 2. Global Nuclear Medical Device Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Nuclear Medical Device Market Share by Type: 2025 & 2032
Figure 4. External Beam Radiotherapy (EBRT) Equipment Product Picture
Figure 5. Brachytherapy Equipment Product Picture
Figure 6. Global Nuclear Medical Device Market Value by Clinical Indication (US$ Million), 2021–2032
Figure 7. Global Nuclear Medical Device Market Share by Clinical Indication: 2025 vs 2032
Figure 8. Oncology Product Picture
Figure 9. Cardiology Product Picture
Figure 10. Neurology Product Picture
Figure 11. Other Product Picture
Figure 12. Global Nuclear Medical Device Market Value by Radionuclide Type (US$ Million), 2021–2032
Figure 13. Global Nuclear Medical Device Market Share by Radionuclide Type: 2025 vs 2032
Figure 14. Beta Emitters Product Picture
Figure 15. Alpha Emitters Product Picture
Figure 16. Gamma Emitters Product Picture
Figure 17. Global Nuclear Medical Device Market Value by Application (US$ Million), 2021–2032
Figure 18. Global Nuclear Medical Device Market Share by Application: 2025 & 2032
Figure 19. Hospitals
Figure 20. Radiation Therapy Center
Figure 21. Global Nuclear Medical Device Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 22. Global Nuclear Medical Device Market Size (US$ Million), 2021–2032
Figure 23. Global Nuclear Medical Device Sales (Units), 2021–2032
Figure 24. Global Nuclear Medical Device Average Price (K US$/Unit), 2021–2032
Figure 25. Nuclear Medical Device Report Years Considered
Figure 26. Nuclear Medical Device Sales Share by Manufacturers in 2025
Figure 27. Global Nuclear Medical Device Revenue Share by Manufacturers in 2025
Figure 28. Top 5 and Top 10 Global Nuclear Medical Device Players: Market Share by Revenue in Nuclear Medical Device in 2025
Figure 29. Nuclear Medical Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 30. Global Nuclear Medical Device Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 31. North America Nuclear Medical Device Sales Market Share by Country (2021–2032)
Figure 32. North America Nuclear Medical Device Revenue Market Share by Country (2021–2032)
Figure 33. U.S. Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Canada Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Europe Nuclear Medical Device Sales Market Share by Country (2021–2032)
Figure 36. Europe Nuclear Medical Device Revenue Market Share by Country (2021–2032)
Figure 37. Germany Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. France Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. U.K. Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Italy Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Russia Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Asia Pacific Nuclear Medical Device Sales Market Share by Region (2021–2032)
Figure 43. Asia Pacific Nuclear Medical Device Revenue Market Share by Region (2021–2032)
Figure 44. China Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Japan Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. South Korea Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. India Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Australia Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Taiwan Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Indonesia Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Thailand Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Malaysia Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Philippines Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Latin America Nuclear Medical Device Sales Market Share by Country (2021–2032)
Figure 55. Latin America Nuclear Medical Device Revenue Market Share by Country (2021–2032)
Figure 56. Mexico Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Brazil Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Argentina Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Middle East and Africa Nuclear Medical Device Sales Market Share by Country (2021–2032)
Figure 60. Middle East and Africa Nuclear Medical Device Revenue Market Share by Country (2021–2032)
Figure 61. Turkey Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Saudi Arabia Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. UAE Nuclear Medical Device Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Global Sales Market Share of Nuclear Medical Device by Type (2021–2032)
Figure 65. Global Revenue Market Share of Nuclear Medical Device by Type (2021–2032)
Figure 66. Global Nuclear Medical Device Price (K US$/Unit) by Type (2021–2032)
Figure 67. Global Sales Market Share of Nuclear Medical Device by Application (2021–2032)
Figure 68. Global Revenue Market Share of Nuclear Medical Device by Application (2021–2032)
Figure 69. Global Nuclear Medical Device Price (K US$/Unit) by Application (2021–2032)
Figure 70. Nuclear Medical Device Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed